Skip to content
  • Prelude has partnered with NutraBloom, which offers expertly-formulated supplements to support your health and fertility. Learn more.

    Prelude has partnered with NutraBloom!


Low risk of fetal chromosome abnormality after mosaic-embryo transfer

November 9th, 2021

While it has been thought that mosaic embryos carry a higher risk for chromosomal abnormalities, Dr. James Grifo and his colleagues at NYU Langone Fertility Center performed a study on patients who received mosaic-embryo transfers and found this risk to be overstated.

Read the full article on